Evaluation of a new chemiluminescent TSH-receptor-antibody (TRAB) microparticle immunoassay

Lee, Deborah J.W.; Phua, Soon Kieng; Liang, Yao; Aw, Tar Choon

doi:10.1016/j.pathol.2022.12.277

Cited by 1 publication

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[55] Competitive immunoassays do not distinguish between stimulating and blocking active antibodies but allow for quantification of the binding capacity of TSH receptor antibodies. [56,57] Bioassays measure the stimulatory or inhibitory effects of TRAb by detecting cAMP production and intracellular TSHR signals. [57,58] ELISA, which is more commonly used in research than in clinical settings, is based on the inhibition of human monoclonal TRAb (M22) binding.…”

Section: Clinical Management Ofmentioning

confidence: 99%

See 1 more Smart Citation

Global research landscape and emerging trends in Graves’ disease: A bibliometric analysis

Yang,

Li,

Zhou

et al. 2024

Medicine

View full text Add to dashboard Cite

Background: Graves’ disease is a prevalent thyroid disorder and is the primary cause of hyperthyroidism. Significant progress has been made in understanding the epidemiology, pathogenesis, diagnosis, treatment, and prognosis of this disease. However, bibliometric analyses on Graves’ disease are lacking. We aimed to comprehensively summarize the research, progression, and focal points of Graves’ disease through data mining and integrated analysis of the existing literature. Methods: We retrieved relevant literature on Graves’ disease from 2003 to 2023 from the Web of Science database. We performed bibliometric analysis using CiteSpace and the R package Bibliometrix. Results: We identified 10,901 publications from 132 countries, with a steady rise in the number of publications over the past 5 years. The US leads in publication volume, with the University of California System being the primary contributing institution. The journal Thyroid had the highest publication output, while the Journal of Clinical Endocrinology and Metabolism was the most frequently cited. These publications involved 2305 authors, with Antonelli Alessandro and Smith Terry being the most prolific. The most frequently cited articles were the “2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis” and the “Thyroid Association/European Group on Graves’ orbitopathy guidelines for the management of Graves’ orbitopathy.” Analysis of the bursts of cited references, keywords, and their clustering revealed that research on Graves’ disease predominantly centers on clinical management, thyroid-stimulating hormone receptors, thyroid hormones, autoimmunity and inflammation, Graves’ ophthalmopathy, thyroid nodules, and thyroid cancer. Conclusion: This is the first comprehensive bibliometric study to summarize progress and trends in Graves’ disease research. These results highlight recent research hotspots and promising directions, thereby providing a valuable reference for other scholars.

show abstract

Section: Clinical Management Ofmentioning

confidence: 99%

“…[59] Several studies have compared instruments from different manufacturers for TSH receptor antibody detection, aiming to identify faster, more sensitive, accurate, and cost-effective detection methods. [56,60,61] 4.2.1.3. Autoimmunity and inflammation.…”

Section: Clinical Management Ofmentioning

confidence: 99%